AP2332A - Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors. - Google Patents

Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors.

Info

Publication number: AP2332A
Authority: AP; ARIPO
Prior art keywords: pyrazole; protein kinase; kinase inhibitors; aminoheteroaryl compounds; substituted aminoheteroaryl
Prior art date: 2004-08-26

Application number

AP2007003906A

Other languages

English (en)

Other versions

AP2007003906A0 (en

Inventor

Jingrong Jean Cui

Lee Andrew Funk

Lei Jia

Original Assignee

Pfizer

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-08-26

Filing date

2005-08-15

Publication date

2011-12-05

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=35677463&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=AP2332(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2005-08-15 Application filed by Pfizer filed Critical Pfizer

2007-02-28 Publication of AP2007003906A0 publication Critical patent/AP2007003906A0/xx

2011-12-05 Application granted granted Critical

2011-12-05 Publication of AP2332A publication Critical patent/AP2332A/xx

Links

125000005214 aminoheteroaryl group Chemical class 0.000 title 1
229940045988 antineoplastic drug protein kinase inhibitors Drugs 0.000 title 1
239000003909 protein kinase inhibitor Substances 0.000 title 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
- A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Plural Heterocyclic Compounds (AREA)
Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Pyridine Compounds (AREA)
Agricultural Chemicals And Associated Chemicals (AREA)

AP2007003906A 2004-08-26 2005-08-15 Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors. AP2332A (en)

Applications Claiming Priority (3)

Application Number	Priority Date	Filing Date	Title
US60524404P	2004-08-26	2004-08-26
US69080305P	2005-06-14	2005-06-14
PCT/IB2005/002695 WO2006021881A2 (en)	2004-08-26	2005-08-15	Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors

Publications (2)

Publication Number	Publication Date
AP2007003906A0 AP2007003906A0 (en)	2007-02-28
AP2332A true AP2332A (en)	2011-12-05

Family

ID=35677463

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AP2007003906A AP2332A (en)	2004-08-26	2005-08-15	Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors.

Country Status (43)

Country	Link
US (1)	US20060128724A1 (sr)
EP (1)	EP1784396B8 (sr)
JP (1)	JP4167295B2 (sr)
KR (1)	KR100869393B1 (sr)
CN (1)	CN101018780B (sr)
AP (1)	AP2332A (sr)
AR (1)	AR050529A1 (sr)
AT (1)	ATE492544T1 (sr)
AU (1)	AU2005276132B2 (sr)
BR (1)	BRPI0514537B8 (sr)
CA (1)	CA2577937C (sr)
CR (2)	CR8938A (sr)
CY (1)	CY1111138T1 (sr)
DE (1)	DE602005025499D1 (sr)
DK (1)	DK1784396T3 (sr)
EA (1)	EA011725B1 (sr)
EC (1)	ECSP077278A (sr)
ES (1)	ES2355923T3 (sr)
GE (1)	GEP20094845B (sr)
GT (1)	GT200500226A (sr)
HN (1)	HN2005000477A (sr)
HR (1)	HRP20110116T1 (sr)
IL (1)	IL181045A0 (sr)
MA (1)	MA28827B1 (sr)
ME (1)	ME01309B (sr)
MX (1)	MX2007002310A (sr)
MY (1)	MY139942A (sr)
NI (1)	NI200700058A (sr)
NL (1)	NL1029809C2 (sr)
NO (1)	NO338656B1 (sr)
NZ (1)	NZ552946A (sr)
PA (1)	PA8643201A1 (sr)
PE (1)	PE20060651A1 (sr)
PL (1)	PL1784396T3 (sr)
PT (1)	PT1784396E (sr)
RS (1)	RS51601B (sr)
SI (1)	SI1784396T1 (sr)
SV (1)	SV2006002208A (sr)
TN (1)	TNSN07071A1 (sr)
TW (1)	TWI300411B (sr)
UY (1)	UY29080A1 (sr)
WO (1)	WO2006021881A2 (sr)
ZA (1)	ZA200701281B (sr)

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GEP20084341B (en) *	2003-02-26	2008-03-25	Sugen Inc	Aminoheteroaryl compounds as protein kinase inhibitors
BRPI0513915A (pt)	2004-08-26	2008-05-20	Pfizer	compostos aminoeteroarila enantiomericamente puros como inibidores de proteìna quinase
US20070072908A1 (en) *	2005-06-08	2007-03-29	Japan Tobacco Inc.	Heterocyclic compounds
RU2387650C2 (ru) *	2005-12-05	2010-04-27	Пфайзер Продактс Инк.	Полиморфы с-met/hgfr ингибитора
DK1959955T3 (da) *	2005-12-05	2011-02-07	Pfizer Prod Inc	Fremgangsmåde til behandling af abnorm cellevækst
BRPI0717320A2 (pt)	2006-10-23	2013-10-22	Sgx Pharmaceuticals Inc	Triazóis bicíclicos como moduladores de proteína cinase
GB0621607D0 (en) *	2006-10-31	2006-12-06	Chroma Therapeutics Ltd	Inhibitors of c-Met
CL2007003609A1 (es)	2006-12-14	2008-07-25	Bayer Schering Pharma Ag	Compuestos derivados de dihidropiridinas sustituidas; proceso de preparacion; compuestos intermediarios; composicion farmaceutica; proceso para producir la composicion farmaceutica; y uso en el tratamiento de una enfermedad mejorada con la inhibicion
CA2675755C (en) *	2007-01-19	2015-10-06	Xcovery, Inc.	Pyridine and pyridazine derivatives as kinase inhibitors
ES2529790T3 (es)	2007-04-13	2015-02-25	Dana-Farber Cancer Institute, Inc.	Métodos de tratamiento de cáncer resistente a agentes terapéuticos de ERBB
US8263585B2 (en)	2007-05-04	2012-09-11	Novartis Ag	Organic compounds
DE102007026341A1 (de)	2007-06-06	2008-12-11	Merck Patent Gmbh	Benzoxazolonderivate
WO2009036404A2 (en)	2007-09-13	2009-03-19	Codexis, Inc.	Ketoreductase polypeptides for the reduction of acetophenones
AU2008315746A1 (en)	2007-10-25	2009-04-30	Astrazeneca Ab	Pyridine and pyrazine derivatives useful in the treatment of cell proliferative disorders
EP2265270A1 (en) *	2008-02-04	2010-12-29	OSI Pharmaceuticals, Inc.	2-aminopyridine kinase inhibitors
AR070317A1 (es)	2008-02-06	2010-03-31	Osi Pharm Inc	Furo (3,2-c) piridina y tieno (3,2-c) piridinas
US8268834B2 (en)	2008-03-19	2012-09-18	Novartis Ag	Pyrazine derivatives that inhibit phosphatidylinositol 3-kinase enzyme
JPWO2009131173A1 (ja)	2008-04-23	2011-08-18	協和発酵キリン株式会社	２−アミノキナゾリン誘導体
KR101034351B1 (ko) *	2008-05-14	2011-05-16	한국화학연구원	신규 벤즈옥사졸로 치환된 피리딘 유도체 또는 이의약학적으로 허용가능한 염, 이의 제조방법 및 이를유효성분으로 함유하는 이상세포 성장 질환의 예방 및치료용 약학적 조성물
BRPI0914305B8 (pt)	2008-06-19	2021-05-25	Xcovery Holding Co Llc	compostos de piridazina carboxamida substituída como compostos inibidores da quinase, uso dos compostos e uso de uma composição compreendendo os compostos
EP2356116A1 (en) *	2008-11-20	2011-08-17	OSI Pharmaceuticals, Inc.	Substituted pyrroloý2,3-b¨-pyridines and-pyrazines
DE102009003975A1 (de)	2009-01-07	2010-07-08	Merck Patent Gmbh	Benzothiazolonderivate
AU2010254053A1 (en) *	2009-05-28	2011-12-01	Vertex Pharmaceuticals Incorporated	Substituted pyrazole inhibitors of c-Met protein kinase
US8486939B2 (en)	2009-07-07	2013-07-16	Pathway Therapeutics Inc.	Pyrimidinyl and 1,3,5-triazinyl benzimidazoles and their use in cancer therapy
DE102009056886A1 (de)	2009-12-03	2011-06-09	Bayer Schering Pharma Aktiengesellschaft	cMet-Inhibitoren zur Behandlung der Endometriose
US8378104B2 (en) *	2010-02-11	2013-02-19	OSI Pharmaceuticals, LLC	7-aminofuropyridine derivatives
JP5805672B2 (ja) *	2010-02-22	2015-11-04	グラクソスミスクライン・リミテッド・ライアビリティ・カンパニーＧｌａｘｏＳｍｉｔｈＫｌｉｎｅＬＬＣ	脂肪酸合成酵素阻害剤としてのトリアゾロン類
WO2011109593A1 (en)	2010-03-03	2011-09-09	OSI Pharmaceuticals, LLC	Substituted-5-aminopyrrolo/pyrazolopyridines
EP2566858A2 (en) *	2010-05-04	2013-03-13	Pfizer Inc.	Heterocyclic derivatives as alk inhibitors
US8513238B2 (en) *	2010-05-10	2013-08-20	Hoffmann-La Roche Inc.	Heteroaryl-cyclohexyl-tetraazabenzo[E]azulenes
JP2013526570A (ja)	2010-05-14	2013-06-24	オーエスアイ・ファーマシューティカルズ，エルエルシー	縮合二環式キナーゼ阻害剤
AR081039A1 (es)	2010-05-14	2012-05-30	Osi Pharmaceuticals Llc	Inhibidores biciclicos fusionados de quinasa
ES2715611T3 (es)	2010-05-17	2019-06-05	Incozen Therapeutics Pvt Ltd	Compuestos novedosos de 3H-imidazo[4,5-b]piridina-3,5-disustituida y 3H-[1,2,3]triazolo[4,5-b]piridina 3,5-disustituida como moduladores de proteína cinasas
CN101857594B (zh) *	2010-06-18	2013-04-03	南方医科大学	一种四氢吡啶并吲哚类化合物及其制备方法和应用
EP2588107A1 (en)	2010-07-01	2013-05-08	Takeda Pharmaceutical Company Limited	COMBINATION OF A cMET INHIBITOR AND AN ANTIBODY TO HGF AND/OR cMET
AU2011276955B2 (en) *	2010-07-09	2014-11-06	The Walter And Eliza Hall Institute Of Medical Research	Protein kinase inhibitors and methods of treatment
CN101967140A (zh) *	2010-09-14	2011-02-09	郑州泰基鸿诺药物科技有限公司	氘代克里唑蒂尼及其衍生物、制备方法和应用
PL2625176T3 (pl)	2010-10-08	2017-08-31	Xcovery Holding Company Llc	Podstawione związki 6-amino-pirydazyn-3-ylo-karboksyamidu jako modulatory kinazy białkowej
US9145390B2 (en)	2011-03-03	2015-09-29	Concert Pharmaceuticals, Inc.	Derivatives of pyrazole-substituted amino-heteroaryl compounds
CA2831582C (en)	2011-03-28	2019-01-08	Mei Pharma, Inc.	(alpha-substituted aralkylamino and heteroarylalkylamino) pyrimidinyl and 1,3,5-triazinyl benzimidazoles, pharmaceutical compositions thereof, and their use in treating proliferative diseases
US20140088114A1 (en)	2011-05-16	2014-03-27	OSI Pharmaceuticals ,LLC	Fused bicyclic kinase inhibitors
CN102850328B (zh) *	2011-07-01	2014-12-24	苏州东南药业股份有限公司	吡啶类化合物、其制备方法、包含该化合物的药物组合物及其用途
US9226923B2 (en)	2011-07-27	2016-01-05	Nanjing Allgen Pharma Co. Ltd.	Spirocyclic molecules as protein kinase inhibitors
WO2013017989A1 (en)	2011-08-02	2013-02-07	Pfizer Inc.	Crizotinib for use in the treatment of cancer
JP2014526524A (ja) *	2011-09-21	2014-10-06	テリジーンリミテッド	キナーゼ阻害剤としてのピリジン化合物
CN103087050A (zh) *	2011-10-28	2013-05-08	山东轩竹医药科技有限公司	芳基激酶抑制剂
LT2822953T (lt)	2012-03-06	2017-04-10	Pfizer Inc.	Makrocikliniai dariniai, skirti proliferacinių ligų gydymui
CN103304552B (zh) *	2012-03-09	2016-12-28	广东东阳光药业有限公司	取代的吡啶化合物及其使用方法和用途
WO2013138210A1 (en) *	2012-03-14	2013-09-19	Ning Xi	Substituted cyclic compounds and methods of use
AU2013205306B2 (en)	2012-03-16	2015-09-17	Axikin Pharmaceuticals, Inc.	3,5-diaminopyrazole kinase inhibitors
CN103319468B (zh) *	2012-03-21	2016-07-13	广东东阳光药业有限公司	取代的螺双环化合物及其使用方法和用途
WO2013144191A1 (de)	2012-03-29	2013-10-03	Bayer Intellectual Property Gmbh	Substituierte 2 -amino - 3 - cyanopyridine als inhibitoren des natrium calcium austausches und ihre verwendung bei kardiovaskulären erkrankungen
CN107082779A (zh)	2012-03-30	2017-08-22	理森制药股份公司	作为c‑met 蛋白激酶调节剂的新化合物
WO2013152252A1 (en)	2012-04-06	2013-10-10	OSI Pharmaceuticals, LLC	Combination anti-cancer therapy
CN103373986B (zh) *	2012-04-22	2016-10-05	东南大学	克里唑替尼前药及其制备方法与用途
KR101582852B1 (ko)	2012-05-24	2016-01-07	서울대학교 산학협력단	타우 단백질 매개 신경 퇴행성 질환 치료제
WO2013181251A1 (en)	2012-05-29	2013-12-05	Ratiopharm Gmbh	Crizotinib hydrochloride salt in crystalline
GB201211310D0 (en)	2012-06-26	2012-08-08	Chroma Therapeutics Ltd	CSF-1R kinase inhibitors
WO2014020467A2 (en)	2012-07-30	2014-02-06	Fresenius Kabi Oncology Ltd	Process for the preparation of pyrazole substituted aminoheteroaryl compounds
JO3215B1 (ar)	2012-08-09	2018-03-08	Phenex Pharmaceuticals Ag	حلقات غير متجانسة بها 5 ذرات تحتوي على النيتروجين بها استبدال بكربوكساميد أو سلفوناميد كمعدلات لمستقبل نووي غير محمي RORy
AU2013307383A1 (en)	2012-08-27	2015-03-26	Cemm - Forschungszentrum Fur Molekulare Medizin Gmbh	Aminoheteroaryl compounds as MTH1 inhibitors
CN103720691A (zh) *	2012-10-11	2014-04-16	韩冰	一类治疗脑性瘫痪的化合物及其用途
WO2014060381A1 (de)	2012-10-18	2014-04-24	Bayer Cropscience Ag	Heterocyclische verbindungen als schädlingsbekämpfungsmittel
US20150299170A1 (en) *	2012-11-21	2015-10-22	Concert Pharmaceuticals, Inc.	Fluoro-derivatives of pyrazole-substituted amino-heteroaryl compounds
TWI498325B (zh) *	2013-01-18	2015-09-01	Hoffmann La Roche	３－取代吡唑及其用途
ES2716617T3 (es) *	2013-02-02	2019-06-13	Chia Tai Tianqing Pharmaceutical Group Co Ltd	Inhibidor de proteína quinasa de 2-aminopiridina sustituida
CN103992307B (zh) *	2013-02-16	2017-07-14	浙江九洲药物科技有限公司	一种克里唑替尼的制备方法
WO2014139391A1 (en) *	2013-03-11	2014-09-18	Teligene Ltd	Substituted pyridine compounds as kinases inhibitors
US9133189B2 (en)	2013-03-14	2015-09-15	Epizyme, Inc.	Arginine methyltransferase inhibitors and uses thereof
US9365527B2 (en)	2013-03-14	2016-06-14	Epizyme, Inc.	Arginine methyltransferase inhibitors and uses thereof
WO2014153208A1 (en)	2013-03-14	2014-09-25	Epizyme, Inc.	Arginine methyltransferase inhibitors and uses thereof
US9120757B2 (en)	2013-03-14	2015-09-01	Epizyme, Inc.	Arginine methyltransferase inhibitors and uses thereof
US9447079B2 (en)	2013-03-14	2016-09-20	Epizyme, Inc.	PRMT1 inhibitors and uses thereof
AU2014260433A1 (en)	2013-03-14	2015-09-10	Epizyme, Inc.	Pyrazole derivatives as arginine methyltransferase inhibitors and uses thereof
WO2014144659A1 (en)	2013-03-14	2014-09-18	Epizyme, Inc.	Pyrazole derivatives as prmt1 inhibitors and uses thereof
WO2014153235A2 (en)	2013-03-14	2014-09-25	Epizyme, Inc.	Arginine methyltransferase inhibitors and uses thereof
HRP20202008T1 (hr)	2013-03-14	2021-02-19	Epizyme, Inc.	Inhibitori arginin-metiltransferaze i njihove uporabe
CN104059054B (zh) *	2013-03-19	2018-11-20	浙江导明医药科技有限公司	用于治疗癌症的三级环状胺alk激酶抑制剂
WO2014203177A1 (en) *	2013-06-18	2014-12-24	Shilpa Medicare Limited	Amorphous (r) -3- [1- (2, 6-dichloro-3-fluorophenyl) methoxy] -5- [1- (piperidin-4- yl) -1h-pyrazol-4-yl] pyridin-2-amine
CN104230890A (zh) *	2013-06-19	2014-12-24	信诺凯（北京）化工有限公司	吡啶-2-胺衍生物及其制法和药物组合物与用途
CN104650049B (zh) *	2013-08-28	2018-06-08	广东东阳光药业有限公司	取代的吡啶化合物及其使用方法和用途
KR101598664B1 (ko)	2013-09-04	2016-03-02	씨제이헬스케어 주식회사	피롤로피리다진 유도체를 포함하는 단백질 키나제 억제제
WO2015034729A1 (en) *	2013-09-05	2015-03-12	Calitor Sciences, Llc	Substituted pyridine compounds and methods of use
NZ631142A (en)	2013-09-18	2016-03-31	Axikin Pharmaceuticals Inc	Pharmaceutically acceptable salts of 3,5-diaminopyrazole kinase inhibitors
RU2643361C2 (ru)	2013-09-30	2018-02-01	Кореа Рисёч Инститьют Оф Кемикал Текнолоджи	Новые производные триазолопиразина и их применение
BR112016021383A2 (pt)	2014-03-24	2017-10-03	Genentech Inc	Método para identificar um paciente com câncer que é susceptível ou menos susceptível a responder ao tratamento com um antagonista de cmet, método para identificar um paciente apresentando câncer previamente tratado, método para determinar a expressão do biomarcador hgf, antagonista anti-c-met e seu uso, kit de diagnóstico e seu método de preparo
WO2015172747A1 (en) *	2014-05-16	2015-11-19	Zhaoyin Wang	Spirocyclic molecules as mth1 inhibitors
CA2955676A1 (en)	2014-08-25	2016-03-03	Pfizer Inc.	Combination of a pd-1 antagonist and an alk inhibitor for treating cancer
WO2016044576A1 (en) *	2014-09-17	2016-03-24	Epizyme, Inc.	Salts, co-crystals, amorphous forms, and crystalline forms of an arginine methyltransferase inhibitor
CN104402868B (zh) *	2014-11-04	2016-08-24	郑州泰基鸿诺医药股份有限公司	氘代克里唑蒂尼晶型及其制备方法
ES2764299T3 (es)	2014-12-09	2020-06-02	Inst Nat Sante Rech Med	Anticuerpos monoclonales humanos contra AXL
CN107250116B (zh)	2014-12-23	2020-10-27	艾士盟医疗公司	3,5-二氨基吡唑激酶抑制剂
WO2016135041A1 (en)	2015-02-26	2016-09-01	INSERM (Institut National de la Santé et de la Recherche Médicale)	Fusion proteins and antibodies comprising thereof for promoting apoptosis
WO2016145383A1 (en) *	2015-03-11	2016-09-15	Board Of Regents, University Of Texas System	Mth1 inhibitors for treating disease
AU2016251253B2 (en)	2015-04-24	2020-07-09	Guangzhou Maxinovel Pharmaceuticals Co., Ltd	Condensed-ring pyrimidylamino derivative, preparation method therefor, and intermediate, pharmaceutical composition and applications thereof
CN106279112A (zh) *	2015-06-12	2017-01-04	浙江九洲药业股份有限公司	一种克里唑替尼中间体及其制备方法和应用
JP2018529719A (ja)	2015-09-30	2018-10-11	メルクパテントゲゼルシャフトミットベシュレンクテルハフツングＭｅｒｃｋＰａｔｅｎｔＧｅｓｅｌｌｓｃｈａｆｔｍｉｔｂｅｓｃｈｒａｅｎｋｔｅｒＨａｆｔｕｎｇ	Ａｌｋ陰性がんを処置するためのｐｄ−１系結合アンタゴニストおよびａｌｋ阻害剤の組合せ
LT3458053T (lt)	2016-05-20	2022-02-25	Biohaven Pharmaceutical Holding Company Ltd.	Riluzolo, rilizolo provaistų arba riluzolo analogų panaudojimas kartu su imunoterapijomis vėžio formų gydymui
TWI646094B (zh)	2016-06-01	2019-01-01	大陸商貝達藥業股份有限公司	Crystal form of inhibitory protein kinase active compound and application thereof
CN106632260B (zh) *	2016-09-29	2019-04-26	上海天慈生物谷生物工程有限公司	一种小分子激酶抑制剂的制备方法
CA3063976A1 (en)	2017-05-23	2018-11-29	Mei Pharma, Inc.	Combination therapy
MX2020001727A (es)	2017-08-14	2020-03-20	Mei Pharma Inc	Terapia de combinacion.
CN110372664A (zh) *	2018-04-13	2019-10-25	华东理工大学	选择性jak2抑制剂及其应用
KR102207608B1 (ko)	2019-04-24	2021-01-26	윤종오	카르복실산으로 유기화된 규소 이온 복합체 및 복합체의 제조방법과 이를 이용한 제품
CN115745979B (zh) *	2021-11-11	2025-09-23	中国医学科学院医药生物技术研究所	一种蛋白靶向降解化合物及其用途
TW202412771A (zh)	2022-07-04	2024-04-01	日商中外製藥股份有限公司	併用醫藥
CN119789871A (zh)	2022-08-30	2025-04-08	中外制药株式会社	并用药物

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003066608A1 (en) *	2002-02-06	2003-08-14	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Catechol bioisosteres
WO2004013091A2 (en) *	2002-08-01	2004-02-12	Yissum Research Development Company Of The Hebrew University Of Jerusalem	4-anilido substituted quinazolines and use thereof as inhibitors of epidermal growth factor receptor kinases
WO2004076412A2 (en) *	2003-02-26	2004-09-10	Sugen, Inc.	Aminoheteroaryl compounds as protein kinase inhibitors

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FI941572L (fi) *	1991-10-07	1994-05-27	Oncologix Inc	Anti-erbB-2-monoklonaalisten vasta-aineiden yhdistelmä ja käyttömenetelmä
DE69333807T2 (de) *	1992-02-06	2006-02-02	Chiron Corp., Emeryville	Marker für krebs und biosynthetisches bindeprotein dafür
US5863949A (en) *	1995-03-08	1999-01-26	Pfizer Inc	Arylsulfonylamino hydroxamic acid derivatives
DK0821671T3 (da) *	1995-04-20	2001-04-23	Pfizer	Arylsulfonylhydroxamsyrederivater som MMP- og TNF-inhibitorer
US5747498A (en) *	1996-05-28	1998-05-05	Pfizer Inc.	Alkynyl and azido-substituted 4-anilinoquinazolines
US5880141A (en) *	1995-06-07	1999-03-09	Sugen, Inc.	Benzylidene-Z-indoline compounds for the treatment of disease
GB9518953D0 (en) *	1995-09-15	1995-11-15	Pfizer Ltd	Pharmaceutical formulations
JPH11512750A (ja) *	1996-06-27	1999-11-02	ファイザーインク．	２―（２―オキソ―エチリデン）―イミダゾリジン―４―オンの誘導体およびファルネシル蛋白質トランスフェラーゼ阻害物質としてのそれらの使用法
JPH11236333A (ja) *	1997-12-30	1999-08-31	Pfizer Prod Inc	抗ガン剤として有用なイミダゾリン−４−オン誘導体
CA2341739C (en) *	1998-08-27	2005-07-12	Pfizer Products Inc.	Quinolin-2-one derivatives useful as anticancer agents
AP2001002079A0 (en) *	1998-08-27	2001-03-31	Pfizer Prod Inc	Alkynyl-substituted quinolin-2-one derivatives useful as anticancer agents.
EP1006113A1 (en) *	1998-12-02	2000-06-07	Pfizer Products Inc.	Derivatives of 2-(2-oxo-ethylidene)-imidazolidin-4-one and their use to inhibit abnormal cell growth
EE05627B1 (et) *	1998-12-23	2013-02-15	Pfizer Inc.	CTLA-4 vastased inimese monoklonaalsed antikehad
UA71945C2 (en) *	1999-01-27	2005-01-17	Pfizer Prod Inc	Substituted bicyclic derivatives being used as anticancer agents
JP3270834B2 (ja) *	1999-01-27	2002-04-02	ファイザー・プロダクツ・インク	抗がん剤として有用なヘテロ芳香族二環式誘導体
ATE297916T1 (de) *	1999-02-11	2005-07-15	Pfizer Prod Inc	Heteroaryl-substituierte chinolin-2-on derivate verwendbar als antikrebsmittel
US6586447B1 (en) *	1999-04-01	2003-07-01	Pfizer Inc	3,3-disubstituted-oxindole derivatives useful as anticancer agents
EP1081137A1 (en) *	1999-08-12	2001-03-07	Pfizer Products Inc.	Selective inhibitors of aggrecanase in osteoarthritis treatment
DK1106612T3 (da) *	1999-11-30	2004-05-17	Pfizer Prod Inc	Quinolinderivater, der er nyttige til inhibering af farnesylproteintransferase
HN2000000266A (es) *	2000-01-21	2001-05-21	Pfizer Prod Inc	Compuesto anticanceroso y metodo de separacion de enantiomeros util para sintetizar dicho compuesto.
US6844357B2 (en) *	2000-05-01	2005-01-18	Pfizer Inc.	Substituted quinolin-2-one derivatives useful as antiproliferative agents
SE0102439D0 (sv) *	2001-07-05	2001-07-05	Astrazeneca Ab	New compounds
SE0102438D0 (sv) *	2001-07-05	2001-07-05	Astrazeneca Ab	New compounds
JP2005538975A (ja) *	2002-07-03	2005-12-22	アステックステクノロジーリミテッド	ｐ３８ＭＡＰキナーゼ阻害薬としての３−（ヘテロ）アリールメトキシピリジン類およびそれらの類縁体
SE0203754D0 (sv) *	2002-12-17	2002-12-17	Astrazeneca Ab	New compounds
DE10307845A1 (de) *	2003-02-25	2004-09-02	Bayer Cropscience Gmbh	Heterocyclische Amide, Verfahren zu ihrer Herstellung, sie enthaltende Mittel und ihre Verwendung als Schädlingsbekämpfungsmittel
BRPI0513915A (pt) *	2004-08-26	2008-05-20	Pfizer	compostos aminoeteroarila enantiomericamente puros como inibidores de proteìna quinase

2005
- 2005-08-15 NZ NZ552946A patent/NZ552946A/en not_active IP Right Cessation
- 2005-08-15 DE DE602005025499T patent/DE602005025499D1/de not_active Expired - Lifetime
- 2005-08-15 AT AT05782821T patent/ATE492544T1/de active
- 2005-08-15 DK DK05782821.2T patent/DK1784396T3/da active
- 2005-08-15 RS RS20110085A patent/RS51601B/sr unknown
- 2005-08-15 GE GEAP20059888A patent/GEP20094845B/en unknown
- 2005-08-15 AP AP2007003906A patent/AP2332A/xx active
- 2005-08-15 EA EA200700321A patent/EA011725B1/ru active Protection Beyond IP Right Term
- 2005-08-15 ME MEP-2011-40A patent/ME01309B/me unknown
- 2005-08-15 PL PL05782821T patent/PL1784396T3/pl unknown
- 2005-08-15 WO PCT/IB2005/002695 patent/WO2006021881A2/en not_active Ceased
- 2005-08-15 JP JP2007529029A patent/JP4167295B2/ja not_active Expired - Lifetime
- 2005-08-15 ES ES05782821T patent/ES2355923T3/es not_active Expired - Lifetime
- 2005-08-15 CA CA2577937A patent/CA2577937C/en not_active Expired - Lifetime
- 2005-08-15 SI SI200531231T patent/SI1784396T1/sl unknown
- 2005-08-15 EP EP05782821A patent/EP1784396B8/en not_active Expired - Lifetime
- 2005-08-15 HR HR20110116T patent/HRP20110116T1/hr unknown
- 2005-08-15 AU AU2005276132A patent/AU2005276132B2/en active Active
- 2005-08-15 BR BRPI0514537A patent/BRPI0514537B8/pt active IP Right Grant
- 2005-08-15 PT PT05782821T patent/PT1784396E/pt unknown
- 2005-08-15 CN CN200580030636XA patent/CN101018780B/zh not_active Expired - Lifetime
- 2005-08-15 MX MX2007002310A patent/MX2007002310A/es active IP Right Grant
- 2005-08-15 KR KR1020077004564A patent/KR100869393B1/ko not_active Expired - Lifetime
- 2005-08-19 MY MYPI20053921A patent/MY139942A/en unknown
- 2005-08-23 UY UY29080A patent/UY29080A1/es active IP Right Grant
- 2005-08-23 AR ARP050103534A patent/AR050529A1/es active IP Right Grant
- 2005-08-24 PE PE2005000974A patent/PE20060651A1/es active IP Right Grant
- 2005-08-24 HN HN2005000477A patent/HN2005000477A/es unknown
- 2005-08-24 GT GT200500226A patent/GT200500226A/es unknown
- 2005-08-25 NL NL1029809A patent/NL1029809C2/nl not_active IP Right Cessation
- 2005-08-25 TW TW094129028A patent/TWI300411B/zh not_active IP Right Cessation
- 2005-08-26 US US11/213,039 patent/US20060128724A1/en not_active Abandoned
- 2005-08-26 PA PA20058643201A patent/PA8643201A1/es unknown
- 2005-08-26 SV SV2005002208A patent/SV2006002208A/es unknown
2007
- 2007-01-29 IL IL181045A patent/IL181045A0/en unknown
- 2007-02-13 ZA ZA200701281A patent/ZA200701281B/xx unknown
- 2007-02-21 CR CR8938A patent/CR8938A/es unknown
- 2007-02-23 TN TNP2007000071A patent/TNSN07071A1/fr unknown
- 2007-02-23 NI NI200700058A patent/NI200700058A/es unknown
- 2007-02-26 MA MA29719A patent/MA28827B1/fr unknown
- 2007-02-26 EC EC2007007278A patent/ECSP077278A/es unknown
- 2007-03-09 NO NO20071320A patent/NO338656B1/no unknown
2011
- 2011-01-27 CY CY20111100092T patent/CY1111138T1/el unknown
2012
- 2012-08-10 CR CR20120421A patent/CR20120421A/es unknown

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2003066608A1 (en) *	2002-02-06	2003-08-14	Yissum Research Development Company Of The Hebrew University Of Jerusalem	Catechol bioisosteres
WO2004013091A2 (en) *	2002-08-01	2004-02-12	Yissum Research Development Company Of The Hebrew University Of Jerusalem	4-anilido substituted quinazolines and use thereof as inhibitors of epidermal growth factor receptor kinases
WO2004076412A2 (en) *	2003-02-26	2004-09-10	Sugen, Inc.	Aminoheteroaryl compounds as protein kinase inhibitors

Also Published As

Publication number	Publication date
MX2007002310A (es)	2007-05-08
BRPI0514537A (pt)	2008-06-17
HN2005000477A (es)	2010-06-09
MA28827B1 (fr)	2007-08-01
ES2355923T3 (es)	2011-04-01
JP4167295B2 (ja)	2008-10-15
RS51601B (sr)	2011-08-31
EP1784396B1 (en)	2010-12-22
CN101018780B (zh)	2012-01-11
EA011725B1 (ru)	2009-04-28
SV2006002208A (es)	2006-10-04
GEP20094845B (en)	2009-11-25
NL1029809A1 (nl)	2006-02-28
NZ552946A (en)	2010-09-30
HRP20110116T1 (hr)	2011-03-31
ECSP077278A (es)	2007-03-29
SI1784396T1 (sl)	2011-03-31
GT200500226A (es)	2006-04-10
MY139942A (en)	2009-11-30
PL1784396T3 (pl)	2011-05-31
CY1111138T1 (el)	2015-06-11
NO20071320L (no)	2007-05-29
PE20060651A1 (es)	2006-07-19
CR8938A (es)	2007-08-14
TNSN07071A1 (fr)	2008-06-02
AU2005276132B2 (en)	2011-09-29
AR050529A1 (es)	2006-11-01
JP2008510788A (ja)	2008-04-10
CA2577937A1 (en)	2006-03-02
HK1105415A1 (en)	2008-04-03
CR20120421A (es)	2012-09-14
ATE492544T1 (de)	2011-01-15
EA200700321A1 (ru)	2007-08-31
KR20070038569A (ko)	2007-04-10
AP2007003906A0 (en)	2007-02-28
CA2577937C (en)	2010-12-21
US20060128724A1 (en)	2006-06-15
CN101018780A (zh)	2007-08-15
NL1029809C2 (nl)	2006-10-17
KR100869393B1 (ko)	2008-11-21
DK1784396T3 (da)	2011-02-14
TW200621751A (en)	2006-07-01
AU2005276132A1 (en)	2006-03-02
NI200700058A (es)	2008-03-07
PT1784396E (pt)	2011-01-27
TWI300411B (en)	2008-09-01
ZA200701281B (en)	2008-12-31
IL181045A0 (en)	2007-07-04
EP1784396B8 (en)	2011-04-20
BRPI0514537B1 (pt)	2020-05-12
UY29080A1 (es)	2006-03-31
WO2006021881A2 (en)	2006-03-02
NO338656B1 (no)	2016-09-26
BRPI0514537B8 (pt)	2021-05-25
PA8643201A1 (es)	2006-06-02
DE602005025499D1 (de)	2011-02-03
WO2006021881A3 (en)	2006-05-18
ME01309B (me)	2013-12-20
EP1784396A2 (en)	2007-05-16

Publication	Publication Date	Title
AP2332A (en)	2011-12-05	Pyrazole-substituted aminoheteroaryl compounds as protein kinase inhibitors.
AP2005003383A0 (en)	2005-09-30	Aminoheteroaryl compounds as protein kinase inhibitors.
IL181384A0 (en)	2007-07-04	Enantiomerically pure aminoheteroaryl compounds as protein kinase inhibitors
ZA200606683B (en)	2008-01-30	Pyrazolotriazines as kinase inhibitors
AP2005003353A0 (en)	2005-09-30	Diazepinoindole derivatives as kinase inhibitors.
EP1794137A4 (en)	2009-12-02	SPECIFIC KINASE INHIBITORS
ZA200709269B (en)	2009-01-28	Protein kinase inhibitors
ZA200606573B (en)	2009-10-28	Pyrazolopyrimidine-derivatives as cyclin dependent kinase inhibitors
IL183276A0 (en)	2007-10-31	Kinase inhibitors
ZA200805028B (en)	2009-12-30	Arylpropionamide, arylacrylamide, arylpropynamide, or arylmethylurea analogs as factor Xla inhibitors
ZA200607648B (en)	2008-06-25	Kinase inhibitors
SI1603570T1 (sl)	2013-03-29	Spojine aminoheteroarila kot zaviralci proteinkinaze
HK1108892A (en)	2008-05-23	Protein kinase inhibitors
HK1090927A (en)	2007-01-05	Pyrazolotriazines as kinase inhibitors
HK1105295A (en)	2008-02-06	Kinase inhibitors
AU2004907155A0 (en)	2005-01-06	Imidazopyrazine-based Kinase Inhibitors
HK1118819A (en)	2009-02-20	Kinase inhibitors
HK1121739A (en)	2009-04-30	Kinase inhibitors
ITPD20040243A1 (it)	2005-01-06	Inserto per sottotacchi.
IL160448A0 (en)	2004-07-25	Kinase compounds